Improving risk equalization with constrained regression
 1.4k Downloads
 6 Citations
Abstract
Stateoftheart risk equalization models undercompensate some risk groups and overcompensate others, leaving systematic incentives for risk selection. A natural approach to reducing the under or overcompensation for a particular group is enriching the risk equalization model with risk adjustor variables that indicate membership in that group. For some groups, however, appropriate risk adjustor variables may not (yet) be available. For these situations, this paper proposes an alternative approach to reducing under or overcompensation: constraining the estimated coefficients of the risk equalization model such that the under or overcompensation for a group of interest equals a fixed amount. We show that, compared to ordinary leastsquares, constrained regressions can reduce under/overcompensation for some groups but increase under/overcompensation for others. In order to quantify this tradeoff two fundamental questions need to be answered: “Which groups are relevant in terms of risk selection actions?” and “What is the relative importance of under and overcompensation for these groups?” By making assumptions on these aspects we empirically evaluate a particular set of constraints using individuallevel data from the Netherlands (N = 16.5 million). We find that the benefits of introducing constraints in terms of reduced under/overcompensations for some groups can be worth the costs in terms of increased under/overcompensations for others. Constrained regressions add a tool for developing risk equalization models that can improve the overall economic performance of health plan payment schemes.
Keywords
Health insurance Risk equalization Capitation Risk selection Constrained regressionJEL Classification
I11 I13 G22Introduction
Several countries have adopted elements of Alain Enthoven’s model of regulated health plan competition [10] which combines affordability of health plans with incentives for cost containment and quality improvement.^{1} A crucial element of Enthoven’s model is the adjustment of health plan payments to predictable variation in medical spending, also referred to as risk equalization (RE). In the absence of premium regulation, RE mitigates incentives for health plans to risk rate their premiums and thereby improves affordability of health plans for the sick. In the presence of premium regulation — as is common in regulated health plan markets — RE mitigates incentives for risk selection and thereby improves incentives for health plans to accept and serve the sick as well as the healthy [20].^{2}
Recent research has shown that even stateoftheart RE models — such as those used under the Affordable Care Act in the United States or those used under the Health Insurance Act in the Netherlands — systematically undercompensate groups of consumers in relatively poor health and overcompensate the complementary groups of consumers in relatively good health [16, 30], exposing health plans and consumers to incentives for risk selection. As described by van de Ven and Ellis [28], risk selection threatens the performance of (regulated) health plan markets since it may reduce (1) the quality of care (because plans may have a disincentive to meet the preferences of the sick), (2) the efficiency of care (because risk selection may be a more costeffective strategy for plans to reduce medical spending than improving the efficiency of care), (3) the efficient sorting of consumers among plans (when market segmentation by risk elevates premiums for particular plans), and (4) the affordability of health plans to the sick (when the same market segmentation causes the sick to face higher premiums). To contend with these potential problems, researchers and policy makers work to improve the properties of health plan payment schemes.^{3} In general, three strategies can be applied to reduce incentives for risk selection in regulated health plan markets: improving RE, increasing risk sharing (e.g., via mandatory reinsurance or risk corridors) and relaxing premiumrate restrictions [28]. This paper focuses on the first strategy.
The conventional approach to reducing under or overcompensation for specific groups is enriching the RE model with new/better risk adjustor variables that indicate membership in these groups. If a group of interest (e.g., persons with congestive heart failure) is explicitly recognized by a risk adjustor variable (e.g., via a diagnostic cost group for “congestive heart failure”), ordinary least squares (OLS, the common estimation method for RE models) ensures that the payment for this group will equal the average medical spending of this group.^{4} For some groups, however, appropriate risk adjustor variables may not (yet) be available. In this paper we study two concrete examples in the setting of the Dutch national health insurance: “users of home care in the previous year” and “users of physiotherapy in the previous year”. These groups are known to be substantially undercompensated by the Dutch RE model. So far, however, the Dutch government has not found appropriate risk adjustor variables to indicate membership in these particular groups. One option considered by the Dutch government is using the indicators “yes/no use of home care in the previous year” and “yes/no use of physiotherapy in the previous year” as risk adjustor variables. The Dutch Minister of Health, however, has acknowledged that these indicators are inappropriate for inclusion in the RE model since they would introduce substantial incentives to overuse these services [37].^{5} Though, as long as the undercompensation of the groups in question continues to persist, health plans are confronted with incentives for risk selection, e.g., by skimping on the quality of home care and physiotherapy.
Van Kleef et al. [34] have proposed reducing the under or overcompensation for a group in case appropriate risk adjustor variables to identify this group are not available by introducing under/overpayments for existing risk adjustor variables that are correlated with membership in this group. For example, if “yes/no use of home care in the previous year” is positively correlated with the risk adjustor variable “yes/no inclusion in any diagnostic cost group (DCG)”, the undercompensation for the home care group can be reduced by increasing the risk equalization payment for people with a DCG. Note that — given the zero sum principle on which RE systems in practice are based — the increase in payments for people with a DCG comes with a decrease of payments for people without a DCG and thus a reduction of the overcompensation for nonusers of home care in the previous year. Though this strategy is intuitively appealing, van Kleef et al. did not provide an analytical solution for calculating the changes in weights for existing risk adjustor variables. In this paper we propose and illustrate an analytical approach to solve this problem that can be easily implemented in practice: constrained leastsquares regression.
In practice, RE models are estimated by OLS regression using a series of indicators as risk adjustor variables. As described by van de Ven and Ellis [28], not all indicators are appropriate for serving as a risk adjustor variable. Examples of inappropriate indicators may include information directly based on costs and utilization which would introduce incentives for overuse and gaming (i.e., discretionary coding by plans or providers seeking to enhance revenues). Recent research, for instance, finds substantial “upcoding” in health plans paid by capitation in the US Medicare program [11]. Another example is health survey information, which may identify a group of interest and be a highly informative predictor of medical spending, but too expensive to collect on a regular basis for everyone in a risk pool. Conventional RE ignores such inappropriate indicators during model estimation. Constrained regression allows for indirect use of such indicators by constraining the estimated coefficients of the RE model to reduce under or overcompensation of the groups identified by these indicators. This constrained regression can improve compensation for these groups by exploiting the empirical correlation between omitted and included indicators. At the same time, however, constraints will introduce under or overcompensation for included groups (compared to OLS). In Section “Theory and concepts” of this paper we will argue that in order to quantify this tradeoff two questions need to be answered: “Which groups are relevant in terms of risk selection actions?” and “What is the relative importance of under and overcompensation for these groups?” By making assumptions on these aspects, we will show empirically that the gains from a wellchosen constraint in terms of improved payment fit for omitted indicators can be worth the costs in terms of reduced payment fit for included indicators.
Our empirical application is the national basic health insurance for curative care in the Netherlands, a wellestablished example of a regulated individual health plan market based on principles of regulated competition [27]. In spite of a sophisticated RE model, policy researchers have identified groups that are systematically under or overcompensated [30]. The two groups we study in this paper are known to be undercompensated by about 1200 euro (users of home care in the previous year) and 900 euro (users of physiotherapy in the previous year) per person per year. So far, the Dutch government has not yet found appropriate risk adjustor variables to improve compensation for these groups.
The paper is structured as follows. Section “Theory and concepts” discusses the method of constrained regression and develops measures for quantifying the tradeoff between improved payment fit for omitted indicators and reduced payment fit for included indicators when using constrained regressions in the context of RE. In Sections “Data and empirical methods” and “Results” we apply our approach to the Dutch RE model of 2015 using data on medical spending and characteristics of nearly all individuals with basic health insurance in the Netherlands (N = 16.5 million). We explore using constrained regressions to address the undercompensation of the users of home care or physiotherapy in the previous year. We apply our measures from Section “Theory and concepts” to show that, generally, some reduction in undercompensation for indicators omitted from the RE model can be worth the increase in under or overcompensation for indicators included in the model. Section “Discussion” discusses our main findings and their implications.
Theory and concepts
Constrained regression
Least squares regression methods choose values for a set of parameters, the estimated coefficients, to minimize the residual sum of squared differences between the actual and fitted values from the regression. A researcher may place constraints on the choice of the coefficients in this minimization for various reasons. One common reason for imposing a constraint is to test a hypothesis about a set of coefficients. For example, to test the hypothesis that earned and unearned income has the same effect on household consumption, a constraint can impose the restriction that the coefficients on these two types of income are the same. The researcher can compare the model fit with and without the constraint using an Fstatistic to test whether the reduction in explained variance is statistically significant; if it is, the hypothesis of constant returns is rejected.
Our motivation for introducing a constraint is different, and is akin to methods of constrained optimization. Health plan payment schemes have multiple objectives subject to tradeoffs. For example, in the design of a public health insurance program, one objective may be to reduce financial risk of the population while another objective may be to reduce public expenditures, with a tradeoff between the two. The locus of efficient policies can be found by maximizing one objective subject to a given level of attainment of the other, by, for example, maximizing financial protection for the population for a given level of public expenditures.^{6} By conducting this maximization for different levels of public expenditure, the researcher can characterize the tradeoff between spending more public money and reducing financial risk of the population.
Introducing constraints into a RE model serves a similar purpose. Constrained least squares regression addresses selection incentives regarding included and omitted indicators simultaneously by pursuing the “usual” objective of a RE model — minimizing squared deviations at the individual level for the included indicators — subject to a maximum value of under or overcompensation for the omitted indicators. By varying the maximum value of this second objective, researchers can trace out the tradeoffs between fit on the included indicators and over or undercompensation on the omitted ones.^{7}
Constrained regressions have been studied previously in the context of RE. Glazer et al. [13] proposed using constrained regression to address selection problems, where the constraints were derived from firstorder conditions for plan profit maximization, with one constraint for each service provided by the plan. RE weights were best fitting given a set of linear constraints that guaranteed a balanced set of incentives for plans to fund all services. This theoretical approach has never been implemented empirically, probably due to the complexity of specifying the constraints. In addition, there was no obvious way to “tighten” or “loosen” the constraints as there is here with the magnitude of undercompensation being the target of the constraint. McGuire et al. [18] and Eijkenaar et al. [8] have used constrained regressions in the context of RE, though for purposes other than addressing selection incentives.
This paper focuses on situations where compensation for omitted variables is desired. This starting point is distinct from that of Schokkaert and van de Voorde [25] who study situations where compensation for omitted variables is not desired. They argue that when omitted indicators for which compensation is not desired (which they refer to as Rvariables)^{8} are correlated with indicators included in the RE model for which compensation is desired (Cvariables), conventional RE leads to biased estimates of coefficients for Cvariables since these will (partly) pick up the variation in spending due to the omitted Rvariables. In Schokkaert and van de Voorde’s terminology our paper exclusively focuses on Cvariables.
Evaluating incentives for selection in RE models
A major purpose of RE models is to mitigate incentives for plans to over or underserve groups among the population. Incentives to underserve enrollees with a mental illness, for example, are created if the payments a plan receives for members of this group fall below the costs they bring to the plan. A RE model that recognizes and pays more for persons with some mental illness diagnoses can reduce the gap between average costs and average payments. However, if the RE model recognizes some but not all mental conditions, a plan might seek to deter persons with mental illness from joining by not contracting with firstbest providers of mental health services—an example of inefficiency created by selection incentives. Incentives for a plan to “distort” its benefits away from the efficient mix to attract/deter have been studied theoretically since Rothschild and Stiglitz [24],^{9} and empirically since the beginning of the use of RE in public insurance programs [21]. In the US context, empirical evidence confirms that plans respond to this type of incentive in service provision.^{10} In the Netherlands, several health plans have reported publicly that the imperfect RE discourages them from improving the quality of care for groups that are systematically undercompensated [29].
Papers and reports concerned with incentives for selection first define the group or groups of concern and then compare average payment for members of the group to average medical spending by simulation methods. Evaluations of payment systems in Medicare and in the marketplaces in the US commonly employ “predictive ratios”, a ratio with simulated RE payments for the group in the numerator and medical spending in the denominator. “Underpayment” is indicated if the predictive ratio is less than 1.0. Evaluating the RE model proposed for the marketplaces, Kautter et al. [14] created subgroups of individuals by predicted spending and computed predictive ratios for these subgroups.^{11} In an evaluation of the CMSHCC model used in Medicare, Pope et al. [22] report predictive ratios for subgroups defined by disease, numbers of prior hospitalizations, demographic characteristics, and other factors.^{12}
Other papers calculate the difference between RE payments and spending to assess selection incentives, with the difference being referred to as “undercompensation” if payments are less than spending and “overcompensation” in the opposite case. Van Kleef et al. [30] merged survey information with health claims for a subset of people in the Netherlands to calculate undercompensation for various groups of people, including those with low physical and mental selfrated health statuses and those reporting chronic conditions. In the current paper we track over and undercompensation, both for defining constraints and as a basis for our evaluation metrics.
In empirical research, both forms of measures, predictive ratios and monetary differences, are primarily applied to groups for whom an indicator is not included in the RE model. The reason is that under the ordinary least squares approach, RE models eliminate under and overcompensation for groups with indicators included in the RE model (see footnote 4). Under a constrained least squares approach, however, over and undercompensation can appear for the latter as well.
Missing from the literature is an accepted method for aggregating grouplevel measures of under and overcompensation to the entire population, or, in other words, there is no accepted summary measure for comparing the comprehensive performance of alternative RE models affecting multiple groups simultaneously. While we can agree that reducing undercompensation for a group of interest is an improvement for that particular group, what if a RE alternative decreases undercompensation for one group but increases it for another? Which RE model is preferred? These questions are directly relevant for this paper since the type of constraints applied here are expected to improve compensation for omitted groups but will generally worsen it for included groups. A weighted sum of under and overcompensations for all groups of concern (both omitted and included groups) is a natural basis for construction of a summary measure with the weight being the share of the population in the group of interest. In the next section, we propose a family of such measures that we apply later to empirically quantify the tradeoff between improved payment fit for some groups and reduced payment fit for others.
A summary measure of selection incentives
As noted previously, to quantify the tradeoff emerging with constrained regressions we need to identify the groups of interest and develop a method for comparing the under and overcompensation for these groups.
Which groups are relevant in terms of risk selection actions?
Newhouse (1993) defines risk selection as “actions by consumers and health plans to exploit unpriced risk heterogeneity and break pooling arrangements. Often the term selection is also used to refer to the outcome of these actions”. In other words: risk selection is about actions (by health plans and consumers) with the intention and/or the outcome that undercompensated groups are (to some extent) separated from overcompensated groups. This implies that evaluation of a RE model starts with stipulating the groups that can be targets of risk selection actions. How would this work? For example, if plans can only take actions that discriminate between people under the age of 65 and those above the age of 65, these become the groups of concern when it comes to (measuring) risk selection (incentives). A RE formula fully addresses selection incentives in this circumstance if it eliminates incentives to favor one group over the other. Analogously, if plans can only discriminate on the basis of “yes/no chronic condition” then these are the two relevant groups. If health plans can discriminate on combinations of “yes/no > 65” and “yes/no chronic condition”, there will be four groups of concern, and so on.
Some research defines groups according to a single geographic indicator under the thinking that a health plan might favor or disfavor certain regions because of systematic differences in medical spending, as was done in a study of Germany by Bauhoff [2]. Other research defines groups according to the services used, the idea being that a health plan could favor or disfavor primary versus some kinds of specialty care, for example, to encourage/discourage potential enrollees anticipating making use of those services.^{13} Since the instruments for health plans to engage in risk selection differ across health care schemes, there is no universal set of relevant groups. Thus, the first step for evaluating incentives for risk selection in a particular setting is to identify the possible selection actions in that setting and to derive the relevant groups. For example, in the Netherlands health plans are unable to discriminate at the individual level due to open enrollment requirements. On the other hand, however, plans can discriminate across groups on the basis of network design. For example, contracting with firstbest physicians for treatment of disease X will attract patients with disease X; conversely, a poor network in terms of quality or convenience will deter patients in that disease group.
What is the relative importance of under and overcompensations for these groups?
Once the relevant groups in terms of selection actions have been identified, the second step for evaluating RE models is to compare the importance of the under and overcompensations for these groups. Literature on selection incentives provides at least four arguments as to why the relative importance of under or overcompensations may differ across groups and vary with the size of these under and overcompensations. A first argument comes from van Barneveld et al. [26] who contend that small predictable profits and losses are likely to be irrelevant for a health plan. Selection can be costly and the net benefits are uncertain, and small incentives may simply not induce a health plan to act. A second argument derived from standard welfare economics is made by Layton et al. [16] who show that the welfare loss from price distortions due to under or overcompensation by a RE model is proportional to the square of the payment gap, implying that the inefficiency from selection goes up more than proportionally with the magnitude of the under and overcompensation. A third argument can be drawn from the work by Ellis and McGuire [9] who argue that selection incentives do not just depend on an indicator’s predictiveness (how well the indicator covaries with total health care spending) but also on predictability of that indicator (how well the indicator can be anticipated) and demand responsiveness of individuals scoring on that indicator. For example, Ellis and McGuire find that both “use of durable medical equipment” and “use of anesthesia” are indicators with high predictiveness but that the first indicator is much more predictable (and therefore much more vulnerable to service level distortion) than the latter. This point implies that potential selection inefficiency of under or overcompensation for one group can be larger than that of an equal under or overcompensation for other groups. A fourth argument comes from van de Ven et al. [29] who contend that the degree of inefficiency depends on the specific selection actions that can occur as a consequence of under or overcompensation. They distinguish many selection actions, such as selective advertising, offering a choice of deductibles, making supplementary insurance (un)attractive for certain groups, offering group contracts, and quality skimping. They argue that of all possible selection actions “quality skimping” is a special threat to the functioning of regulated health plan markets because it not only reduces market efficiency, but also the quality of medical care. Incentives for quality skimping, however, are only present when groups with relatively strong preferences for high quality are undercompensated.^{14} After all, if these groups would be overcompensated, health plans would have incentives to improve quality of care. Thus, for groups with strong preferences for high quality — presumably those with a chronic condition — undercompensation may be worse than overcompensation.^{15}
A summary measure of under and overcompensation for relevant groups

s_{g} the share of the population in group g, with ∑_{g}s_{g} = 1,

\(\bar{r}_{\text{g}}\) the average plan revenue for a person in group g,

\(\bar{c}_{\text{g}}\) the average plan cost for a person in group g, and

\(\bar{r}_{\text{g}}  \bar{c}_{\text{g}}\), the average under/overcompensation for a person in group g.
Given these parameters, under and overcompensations can be summarized by \(\mathop \sum \nolimits_{\text{g}} {\text{s}}_{\text{g}} \left {\bar{r}_{\text{g}}  \bar{c}_{\text{g}} } \right\), i.e., the sum of absolute under and overcompensations weighted by the share of the affected population. We follow standard assumptions (used in calculation of both predictive ratios and over/undercompensation) by regarding medical spending as plan cost and figuring over and undercompensation for an average plan.^{17} With this, in the Dutch context, over and undercompensation is solely a function of the RE payments.^{18} Specifically, average plan revenues equals average predicted spending from the RE model and \(\left {\bar{r}_{\text{g}}  \bar{c}_{\text{g}} } \right\) boils down to absolute residual spending for group g from the RE model. Moreover, \(\mathop \sum \nolimits_{\text{g}} {\text{s}}_{\text{g}} \left( {\bar{r}_{\text{g}}  \bar{c}_{\text{g}} } \right)\) equals zero.
The summary measure \({\mathcal{L}}\) is intuitive, weighting under/overcompensation raised to a power by the share of the affected population, and is easy to compute. \({\mathcal{L}}\) has a minimum value of 0 and no upper bound. Comparing \({\mathcal{L}}\) for RE models is meaningful only for comparing models estimated on the same data with the same definitions of group membership. In our empirical analyses we estimate all RE models on exactly the same data with exactly the same group definition. Under this procedure, RE scheme 1 will be said to be preferred to scheme 2 if \({\mathcal{L}}_{\text{1}} < {\mathcal{L}}_{2}\).
As we noted at the outset of this section the relevant form of Eq. (1) depends on stipulation of the relevant groups and definition of the relative importance of under and overcompensation, which are not straightforward decisions. Taking these factors into account would ideally be based on an elicitation of the concerns of regulators and an analysis of what actions plans can take and the welfare consequences of these actions. We intend the current paper to be a “proof of concept” of the idea of using constraints in a RE model. We select a subset of the groups that are relevant in terms of selection and assume a simple weighting function of under and overcompensation.
As we explain in the “Data and empirical methods” Section, our groups are categorized by a set of indicators included in the current Dutch RE model and a set of indicators omitted from the model. The utility of constraints on regression coefficients emerges when at least one indicator is omitted from the RE model. We will use the included and the omitted indicators jointly to define mutually exclusive groups for the entire Dutch population, and compute \({\mathcal{L}}\) for this partition of the population. We also will compute \({\mathcal{L}}\) for the two sets of included and omitted indicators separately. These two partial classifications allow us to show the effect of constraints on groups identified by the included versus the omitted indicators. Tightening the constraint improves things for the omitted indicators but imposes a cost on fit among the included indicators.
Data and empirical methods
Data
The empirical analyses are based on administrative data including individuallevel information on medical spending and risk indicators for almost the entire Dutch population in 2012 (N = 16.5 million). These data come from various sources, including health plans, tax authorities and the registration service for social benefits.^{21} The resulting merged data are those used to estimate the RE model for health plan payment in the Netherlands in 2015. As a first step in our analyses we faithfully replicate this model, such that our “base model” accurately indicates expected over and undercompensation in the Netherlands for 2015 [8]. Our alternative RE models and simulations modify this base model and are estimated on the same data. Here we briefly describe the risk indicators included in the base model and provide some general statistics.
The Dutch RE model for 2015 is the product of more than 20 years of research and experience and includes the following indicators: 40 risk classes based on an interaction between age and gender, 25 risk classes based on the use of specified prescription drugs in the previous year referred to as pharmacybased cost groups or PCGs [15], 16 risk classes based on diagnostic information from hospital treatment in the previous year referred to as diagnosesbased cost groups or DCGs [23, 33], seven risk classes for people with high costs in multiple prior years referred to as multipleyear high cost groups or MHCGs [32], five risk classes based on the use of durable medical equipment in the previous year referred to as durable medical equipment cost groups or DMECGs [31], four risk classes based on an interaction between two age groups and yes/no “PCG + DCG + MHCG + DMECG > 0”, 12 risk classes based on an interaction between socioeconomic status and age, 10 risk classes based on regional characteristics and 19 risk classes based on an interaction between source of income and age. All risk indicators have been carefully developed in research programs sponsored by the Dutch Ministry of Health. For further details on these risk indicators, see van Kleef et al. [30].^{22}
The RE model of 2015 was estimated by a leastsquares regression with medical spending in 2012 as the dependent variable and the risk classes described above as 138 independent dummy variables.^{23} Medical spending includes the expenses on primary care, pharmaceuticals, hospital inpatient and outpatient care, maternity care, obstetrics and medical devices among other categories, but excludes expenses on mental health care and home health nursing care.^{24} Although the latter two categories of spending are included in the mandatory benefit package of 2015, they are omitted from the main RE model, with funds allocated for them using a separate RE model. In this paper we will be concerned with the primary RE model used to allocate more than 80% of health care costs among health plans in the Netherlands in 2015 [8]. We refer to the RE model of 2015 as the “base model”.
Population frequency and medical spending (in euros, 2012) at aggregated levels of risk characteristics (N = 16.5 million)
Population frequency (%)  Medical spending  

Mean  SD  
Men, <65  42  1207  5893 
Men, ≥65  8  4612  11,050 
Women, <65  41  1487  5212 
Women, ≥65  9  4123  8889 
Region, clusters 1–5  50  1979  6941 
Region, clusters 6–10  50  1719  6237 
Source of income, reference group (age <18 or >64)  38  2477  8235 
Source of income, disability benefits  5  3817  10,570 
Source of income, social security benefits  2  2321  7110 
Source of income, student  3  588  2717 
Source of income, selfemployment  4  1012  3814 
Source of income, other (including employment)  48  1282  4541 
Socioeconomic status, home address >15 residents  1  4507  10,219 
Socioeconomic status, income deciles 1–3  30  1842  6526 
Socioeconomic status, income deciles 4–7  40  1869  6527 
Socioeconomic status, income deciles 8–10  30  1721  6555 
Pharmacybased cost group (PCG)  
No  82  1212  5199 
Yes  18  4751  10,417 
Diagnosesbased cost group (DCG)  
No  91  1353  4921 
Yes  9  6855  14,530 
Durable medical equipment cost group (DMECG)  
No  99  1772  6382 
Yes  1  10,933  17,099 
Multipleyear high cost group (MHCG)  
No  94  1378  4957 
Yes  6  9536  17,056 
PCG, DCG, DMECG and/or MHCG  
No  77  984  4106 
Yes  23  4784  11,090 
Total population  100  1848  6597 
In addition to the administrative data, we use health survey information to assess how constraints on undercompensation for one omitted group affect estimates of over and undercompensation for a series of other omitted groups of interest. The survey was conducted in 2011 among a representative sample of the Dutch population and includes a broad range of questions on general health status, physical impairments, mental health problems, particular chronic diseases and prior utilization of medical care. A unique, anonymous person identifier allows merging the survey information with the administrative data. We calculate under and overcompensation for survey groups as the predicted expenses from a RE model estimated on the administrative data (N = 16.5 million) minus the actual expenses. In contrast to the administrative data, the survey data are available only for a small sample (N = 14,310) of the population, implying that under or overcompensation for groups identified from the survey may be vulnerable to random variation. We report on groups for which under or overcompensation by the base model is statistically significant. For the specific definition of these groups see van Veen et al. [35], Appendix 2).
Selecting study indicators included and study indicators omitted from the RE model
For our empirical application we assume that health plans are able to discriminate on the basis of the following information: “yes/no use of home care in the previous year”, “yes/no use of physiotherapy in the previous year”, and DCGs. The first two indicators are omitted from the Dutch RE model while the DCGs are included. This set of indicators allows study of how constrained regression methods affect fit for groups defined by both omitted and included indicators.
Population frequency, medical spending and under/overcompensation by the Dutch RE model of 2015 (base model) in euros (2012) for the 4 omitted and 16 included indicators studied in our empirical analyses (N = 16.5 million)
Population frequency (%)  Medical spending  Under/overcompensation base model  

Mean  SD  
Omitted indicators  
Use of home care in t−1  
No  97.31  1659  5985  34 
Yes  2.69  8696  16,541  −1231 
Use of physiotherapy in t−1  
No  97.62  1737  6313  23 
Yes  2.38  6422  13,124  −922 
Included indicators  
No DCG  91.00  1353  4921  0 
DCG1  0.67  5573  8943  0 
DCG2  1.49  4649  8100  0 
DCG3  1.11  4196  8243  0 
DCG4  1.80  5058  9541  0 
DCG5  1.16  6291  11,420  0 
DCG6  1.26  7645  13,461  0 
DCG7  0.55  8832  15,511  0 
DCG8  0.12  10,039  15,978  0 
DCG9  0.30  9582  18,583  0 
DCG10  0.33  13,175  20,678  0 
DCG11  0.04  14,557  25,078  0 
DCG12  0.07  17,107  28,243  0 
DCG13  0.04  25,105  41,154  0 
DCG14  0.04  90,296  42,858  0 
DCG15  0.01  62,451  110,800  0 
Total population  100  1848  6597  0 
Each of our omitted indicators “yes/no use of home care in the year t−1” and “yes/no use of physiotherapy in the year t−1” partitions the population into two mutually exclusive groups.^{26} Given the zerosum principle of the Dutch RE model (and the constrained models estimated in our empirical analyses), reductions in undercompensation for the “yes” groups imply corresponding reductions in overcompensation for the complementary “no” groups. For example, if the undercompensation for users of home care reduces by 40%, the overcompensation for the complementary group of nonusers will reduce by 40% too. For simplicity of presentation we primarily focus on the two “yes” groups. As shown in Table 2, these two groups comprise 2.7% and 2.4% of the population in year t, respectively. Both groups are systematically undercompensated by the current Dutch RE model. So far, however, the Dutch government has not found appropriate risk adjustor variables to indicate membership in these particular groups [37]. For some analyses we convert the two yes/no indicators into four mutually exclusive categories by crossing the indicators and classifying the population as having none, home care only, physiotherapy only, or both indicators in the previous year.
Constraining coefficients in the RE models
We introduce a series of constraints to the base RE model that limit the under/overcompensation for one or more omitted indicators with a fixed percentage. This works as follows.
An interesting feature of constraints in this form is that they do not require that information on yes/no membership of g is available for the entire risk pool. Instead, it is sufficient to have a good approximation of the average per person medical spending for g, as well as the mean indicators values conditional on g [see Eq. ((3)]. Information on these parameters obtained from a decent sample of the risk pool (e.g., respondents of a health survey) could be sufficient.
Empirical analyses
As shown in Table 2, the Dutch RE model of 2015 (our “base model”) leads to an average per person undercompensation of 1231 euros for users of home care in the previous year and 922 euros for users of physiotherapy in the previous year. Given these magnitudes, we begin by estimating a series of constrained regressions, where in each case there is just one constraint. For each of the two omitted indicators we reduce the undercompensation in series by 20, 40, 60, 80 and 100%. For each model we calculate measures of overall fit (Rsquared and Cummings prediction measure (CPM)) as well as measures for group fit (under or overcompensation for included and omitted groups).^{27} To quantify the tradeoff between improved fit for omitted groups and deteriorated fit for included groups we track a series of our summary measure (1) based on the mutually exclusive set of four groups identified by the omitted indicators, the mutually exclusive set of the 16 included DCGs, and for the crossproduct of the two sets (64 groups). We also consider a range of powers to apply to the payment gap for each group of interest in order to check the sensitivity of results to the form of the weighting function. In a next step, guided by the results for the single constraints, we try several combinations of constraints for the two omitted indicators to check whether two constraints can produce better overall model performance than any single constraint. We find a superior twoconstraint specification that performs better than any model with a single constraint.
Results
Results (euros, 2012) for the base model and for ten singleconstraint models
Rsquared (×100%)  CPM (×100%)  

Base model  22.5%  24.8% 
Base model + single constraint to limit undercompensation for users of home care in t−1 by:  
20%  22.5%  24.9% 
40%  22.5%  24.9% 
60%  22.4%  24.9% 
80%  22.3%  24.9% 
100%  22.2%  24.8% 
Base model + single constraint to limit undercompensation for users of physiotherapy in t−1 by:  
20%  22.5%  24.9% 
40%  22.5%  25.0% 
60%  22.4%  25.0% 
80%  22.2%  25.0% 
100%  22.0%  24.8% 
Figure 1 also shows that, as expected, the constraint for the omitted group introduces over and undercompensation for the group indicators included in the RE model. The small numbers represent the overcompensation for the 15 DCGs while the large “0” represents the undercompensation for those without a DCG. For the latter group the constrained models introduce an undercompensation up to 40 euros per person per year; for the DCGs the models with constraints introduce overcompensation up to 1280 euros per person per year. The direction of these under and overcompensations can be explained by the positive correlation between the omitted groups and the DCGs: since the home care and physiotherapy groups have relatively high proportions of people in a DCG (not shown here), the constrained model overcompensates the DCGs in order to move funds to these omitted groups.^{28} Like the reduction in undercompensation for users of home care, the change in under or overcompensation for the other groups in Fig. 1 is also linear, a consequence of constrained leastsquares estimators with linear constraints.^{29}
Though the group results in Figs. 1, 2 and 3 are informative, they cannot evaluate tradeoffs between the improvement for omitted groups and the worsening for included groups. As argued in Section “Theory and concepts” of this paper, evaluating the tradeoff can be based on a mutually exclusive grouping of individuals and a weighting of under and overcompensation, as is done by our summary measure proposed in Section “Theory and concepts”. The essence of the summary measure in (1) is that weighted under or overcompensations are computed and aggregated for mutually exclusive groups.
The results presented above clearly show that for a mutually exclusive set of the selected included and omitted indicators, a singleconstraint model can outperform the base model. A natural next question is whether adding a second constraint to the model can lead to further improvements. To check this in our case we started with the most effective single constraint for home care according to our summary measure with p = 2: reducing the undercompensation for home care by 80%. (This is the minimum of the Ushaped dotted line corresponding to p = 2 from Fig. 6a). We introduced the additional constraint that the undercompensation for physiotherapy should be reduced by 20% from the base model, and then should be reduced by 40%. The value of the summary measure (the WMSD) fell by slightly more than 1% of its value with the first constraint at a target undercompensation for physiotherapy of 20% less, but then went up as the second constraint was tightened to the 40% drop in undercompensation. While the improvement obtained by introducing the second constraint is considerably less when the first constraint is roughly optimized, the results show that in terms of the summary measure applied here, a twoconstraint model can outperform a singleconstraint model.
For example, consider the group on the lefthand side of Fig. 7, those reporting their health status to be in the lowest three categories: bad, poor or moderate, composing 19% of the population. These people are undercompensated by an average of 331 euros in the base model. If we impose the constraint eliminating the undercompensation for home care, the undercompensation for the badpoormoderates falls to 118 euros, and if we impose instead the constraint that we eliminate the undercompensation for physiotherapy, the undercompensation disappears altogether (to only 8 euros). Remarkably, for all eight of the undercompensated groups, imposing either constraint has a meaningful favorable impact on the undercompensation. The constraints also improve payments for the groups that were overcompensated, as shown on the righthand side of Fig. 7. The 67% of the population with no chronic illness were overcompensated by 116 euros in the base model, and this is cut to 32 with the home care constraint imposed and 16 if the physiotherapy constraint is imposed.
The findings in Fig. 7 have two important implications. First, the observation that under and overcompensations for the groups in the figure change substantially as a result of a constraint implies that an appropriate tradeoff between the benefits and costs of a constraint requires involving all groups of interest. This emphasizes the importance of the questions raised in Sect. “Theory and concepts”, i.e., “Which groups are relevant in terms of risk selection actions?” and “What is the relative importance of under and overcompensation for these groups?” Second, the direction of the changes in under and overcompensation in Fig. 7 implies that the benefits of constrained regression may reach far: a single constraint intended to improve payment fit for one relevant omitted group can lead to an improvement for many others.
Discussion
The natural way to improve RE models for particular groups is to add new/better risk adjustor variables indicating membership in these groups. But what if appropriate risk adjustor variables are not (yet) available? For these situations, this paper proposed constraining the estimation coefficients of the RE model in order to reduce the under or overcompensation of the group(s) of interest to a fixed amount. Compared to OLS, constraints reduce model fit in terms of Rsquared. Our empirical application of constrained regression to the Dutch RE model of 2015, however, shows that the magnitude of this reduction may be small. An alternative fit measure, the Cummings prediction measure (CPM) also changes little with the introduction of the constraints considered here. On the basis of our results, an Rsquared or CPM should be supplemented with other measures when evaluating constrained regression models, since Rsquared and CPM appear to be insensitive to changes in grouplevel fit induced by the introduction of the constraints considered here.
At a group level, a constraint limiting under or overcompensation for an omitted group comes at the cost of introducing under or overcompensation for included groups. To illustrate our proposed method, we have chosen potentially relevant groups to study and selected a general summary measure to quantify the tradeoffs involved. With these assumptions, we find that the improvement for omitted groups can outweigh the deterioration for included groups. Moreover, multiple constraints can reduce selection incentives over a single constraint. Although we study a particular application of constrained regressions, we have no reason to think these findings are special to this empirical setting. If an indicator for an omitted group of interest is correlated with variables already included in the RE model, it should generally be possible to introduce at least a modest constraint that makes firstorder cuts in undercompensation for the group with the omitted indicator at the cost of only “marginal” over/undercompensation for groups based on included indicators. It will be worthwhile to investigate the conditions (if they exist) under which introduction of a constraint at the margin is associated with a model improvement, perhaps using envelopetheorem type arguments. In any case, the practical performance of constraints in a particular plan payment application is straightforward to assess systematically for each setting.
This paper is intended to be a “proof of concept.” Ultimately, to be useful in terms of plan payment redesign, application of constrained regression methods requires stipulating the groups that can be a target of selection actions and valuing the under or overcompensation for these groups. This exercise starts with identifying the possible selectionrelated actions in a certain context. For example, when insurers might discriminate on the basis of “yes/no use of home care in the prior year”, these are the two relevant groups to distinguish. When insurers are able to discriminate on the basis of combinations of “yes/no use of home care in the prior year” and “yes/no inclusion in any DCG”, these are the four relevant groups to distinguish, and so on.^{31} A mismatch between the (potential) selection targets and the groups distinguished in the summary measure may result in misleading outcomes. So, compared to standard measures used for evaluation of risk equalization models — such as the Rsquared, CPM and predictive ratios — our summary measure is more complex since it requires information about (potential) selection actions in a certain context (as a basis for stipulating the relevant groups) and the effects of these actions (as a basis for valuing the under and overcompensations for these groups). When it comes to selection incentives, however, our measure is also more meaningful.
We believe our approach offers an opportunity to expand the role of regulators and public policy makers. Rather than being reactive to problems identified in empirical studies of RE models, regulators can be proactive and take steps to define the objectives that will be maximized by RE model estimation. Further research is clearly necessary to find a process by which a social consensus can be reached about defining groups of concern for protection against incentives for selection. Once consensus has been reached, however, the “objective” of a RE model can be quantified in the form of a measure like the one used in this paper. Optimization of an explicit objective function with respect to payment weights on included indicators implies a new way for estimating parameters of a RE model. We regard this to be an important area for ongoing research on selection incentives and risk equalization.
Footnotes
 1.
By “health plan competition” we mean competition among health insurers who offer one or multiple health plans. A “health plan” refers to a health insurance product. All consumers who have the same “health plan” have an identical contract with the same insurer concerning benefits coverage, costsharing, quality, services, etc. Since objectives and strategies of insurers can differ across health plans, this paper will speak of health plans instead of insurers as decision makers.
 2.
Newhouse [20] defines risk selection as actions by consumers and health plans to exploit unpriced risk heterogeneity and break pooling arrangements. Often the term selection is also used to refer to the outcome of these actions.
 3.
By “health plan payment scheme” we mean the total set of payment features, which can include risk equalization, reinsurance, risk corridors and premiums among other features.
 4.
The expected value of an OLS residual conditional on a dummy variable regressor is zero. The statistical residual from an OLS model is the individuallevel over or underpayment in a RE model based on the regression coefficients.
 5.
In the presence of such risk adjusters, providing more home care and physiotherapy in the current year will lead to higher RE payments in the next year.
 6.
A closely related and wellknown application of this approach can be found in the Appendix “On Optimal Insurance Policies” of Kenneth Arrow’s Uncertainty and the welfare economics of medical care [1].
 7.
The form of constraints we use is written out in the “Data and empirical methods” Section of this paper. See, in particular, Eq. (2).
 8.
An example of an Rvariable might be an indicator for smoking. Smoking may predict higher medical spending but it may be undesirable to “reward” the health plan of a smoker by higher RE payments.
 9.
 10.
Cao and McGuire [4] in Medicare and Eggleston and Bir [6] in employerbased insurance find patterns of spending on various services consistent with servicelevel selection among competing atrisk plans. Ellis et al. [7] rank services according to incentives to undersupply them. Consistent with servicelevel selection, they show that HMOtype plans tend to underspend on services (in relation to the average) just as the selection index predicts. This pattern of spending is not observed among enrollees in unmanaged plans. See also Carey [5].
 11.
Defining subgroups of the population on the basis of predicted spending can lead to predictive ratios close to 1.0 even if the prediction model itself is weak, and therefore is not necessarily a mark in favor of the RE model. Unless the model itself does a good job at differentiating high from lowcost individuals, a predictive ratio according to a ranking by predicted spending is not very informative.
 12.
Other measures of individual and group fit have been proposed and applied in the literature (see [36] for a review).
 13.
 14.
In a zerosum RE payment scheme, undercompensation of the chronically ill implies overcompensation of the complementary group of healthy individuals, and vice versa.
 15.
Note that constrained regression can be a tool for changing undercompensation for groups of chronically ill into overcompensation. A related argument is made by Lorenz [17] who also identifies empirical methods that weight over and undercompensation asymmetrically.
 16.
The discussion in this section draws on Layton et al. [16] who derive a similar summary measure starting with conditions for profit maximization by a health plan.
 17.
This avoids concerns with selection across plans, differential premiums, and differential plan efficiency.
 18.
In practice multiple payment features may coexist (e.g., risk equalization and reinsurance). Practical use of our summary measure should incorporate all these relevant features. For example, reinsurance figures into plan payments in marketplaces in the US. Simulating payments recognizing these plan payment features can be used in calculating predictive ratios or over/undercompensation [16, 32].
 19.
See Van Veen et al. [36] for discussion of the various statistical measures applied to evaluation of RE schemes.
 20.
Layton et al. [16] propose a metric similar to (1) with p = 2, squaring the paymentcost gap for each group, also appealing to the usual form of welfare loss in economics, in which the area of a welfare triangle is proportional to the square of a discrepancy between the firstbest and the actual price. Their selection metric measures improvement in incentives over a payment system with no premium categories and no RE, and falls between 0 and 1. Lorenz [16] considers situations in which over and undercompensation may impose different magnitudes of losses, and estimators that would be appropriate for minimizing the asymmetric loss functions.
 21.
In estimating the RE model for 2015, medical spending from 2012 has been adjusted to reflect mandatory coverage changes in the period 2013–2015. In a second stage coefficients were linearly adjusted for expected cost inflation. For reasons of simplicity we excluded the second stage from our analysis.
 22.
A complete description of the Dutch payment system would include some subsidiary (and less welldeveloped) RE models for some small cost categories, and description of some of the regional adjustments built into the main model. These details are not important for our simulations. Readers are referred to Eijkenaar et al. [8] for full details on the RE models.
 23.
Analogous to the RE methodology in the Netherlands, medical spending in 2012 (dependent variable) is annualized by dividing actual individuallevel costs of 2012 by the fraction of the year an individual was enrolled in the basic health insurance in 2012. Subsequently, this “fraction” is included as a weight in the estimation model and computation of means. For example, an individual who was enrolled for 6 months and had 1000 euros expenses is given annualized costs of 2000 euros (1000/0.5) and a weight of 0.5.
 24.
Since medical expenses for home care itself are excluded, the undercompensation of about 1200 euros on users of home care implies that prior use of home care has predictive value for other types of medical expenses. A possible explanation is that users of home care have a relatively high probability of dying.
 25.
The DCG classification was developed in several steps. First, a team of medical experts carefully determined whether or not diagnoses refer to a chronic condition. Diagnoses referring to a chronic condition were categorized in 144 more or less clinically homogeneous groups, which — in a next step — were clustered into 15 DCGs based on residual cost (according to a prediction model including explanatory variables based on age, gender and PCGs) using Ward’s hierarchical clustering method. If enrollees have multiple diagnoses that would fall into different DCGs, they are classified in only one DCG, i.e., the one with the highest estimated coefficient. For further details about the Dutch DCGs see Van Kleef et al. [33].
 26.
These indicators are based on the use of home care and physiotherapy as far as covered by the Dutch basic benefit package of 2015. This benefit package fully covers the use of home care. Physiotherapy is only covered for treatment of certain chronic conditions and above a threshold of 20 visits.
 27.
Rsquared is computed as \(1  \frac{{\mathop \sum \nolimits_{{{\text{i}} = 1}}^{\text{n}} ({\text{Y}}_{\text{i}}  \hat{Y}_{\text{i}} )^{2} }}{{\mathop \sum \nolimits_{{{\text{i}} = 1}}^{\text{n}} ({\text{Y}}_{\text{i}}  \bar{Y})^{2} }}\). CPM is computed as \(1  \frac{{\mathop \sum \nolimits_{{{\text{i}} = 1}}^{\text{n}} {\text{Y}}_{\text{i}}  \hat{Y}_{\text{i}} }}{{\mathop \sum \nolimits_{{{\text{i}} = 1}}^{\text{n}} {\text{Y}}_{\text{i}}  \bar{Y}}}\).
 28.
Payment weights patterns under a constrained regression are consistent with the finding in Glazer and McGuire [12] that optimal risk adjusted weights should reflect the correlation between indicators part of the risk equalization and omitted factors affecting health care expenses.
 29.
This can be shown by writing out the formula for the estimated coefficients in constrained least squares. Suppose we seek to estimate a vector β of regression coefficients on j variables X subject to q linear constraints of the form Q ^{T} where Q is a j × q matrix of full rank and the superscript T indicates the transpose of a matrix. Y is a q × 1 vector of constants. One of these q equations could be interpreted in our context as a constraint that the average payment for a target group is equal to an amount “y.” The constrained estimator is \(\hat{\beta }^{c} = \hat{\beta }  \left( {X^{\text{T}} X} \right)^{  1} Q\left( {Q^{\text{T}} \left( {X^{\text{T}} X} \right)^{  1} Q} \right)^{  1} (Q^{\text{T}} \hat{\beta }  \, y)\). From this it is clear that \({\text{d}}\hat{\beta }^{\text{c}} /{\text{dy}}\) is constant.
 30.
The test is a twosided ttest that the difference between payment and cost for individuals in each group equals zero.
 31.
This can be illustrated with the outcomes of the model that constrains the estimated coefficients such that the average undercompensation for people with use of home care in the prior year equals zero. While for the entire group of people with use of home care in the prior year the average undercompensation indeed equals zero (see Fig. 1), this is not the case for subsets of this group on the basis of “yes/no inclusion in any DCG”: those without a DCG (1.7% of the population) are undercompensated by 41 euros while those with a DCG (1.0% of the population) are overcompensated by 65 euros (not shown in Tables and Figures). This implies that evaluation of incentives for selection under a certain risk equalization model requires knowledge about the level at which selection (potentially) takes place.
Notes
Acknowledgements
We gratefully acknowledge the Dutch Ministry of Health, the Association of Health Insurers and Statistics Netherlands for providing the administrative and survey data (see Section “Data and empirical methods”). McGuire is grateful for support from the National Institute of Mental Health (R01 MH094290) and the Laura and John Arnold Foundation. The views expressed here are not necessarily those of the Foundation’s officers, directors or staff. We also gratefully acknowledge the valuable comments on previous versions of this paper by Konstantin Beck, Frank Eijkenaar, Randall Ellis, Laura Hatfield, Timothy Layton, Erzo Luttmer, Joseph Newhouse, SharonLise Normand, Bastian Ravesteijn, Sherri Rose, Erik Schut, Mark Shephard, Suzanne van Veen and anonymous reviewers. In addition, we thank Andrew Hicks for creating the figures. The responsibility for the content of this article rests fully with the authors.
References
 1.Arrow, K.J.: Uncertainty and the welfare economics of medical care. Am. Econ. Rev. 5, 941–973 (1963)Google Scholar
 2.Bauhoff, S.: Do health plans risk select? An audit study on the Germany’s social health insurance. J. Public Econ. 96, 750–759 (2012)CrossRefGoogle Scholar
 3.Breyer, F., Bundorf, M.K., Pauly, M.V.: Health care spending risk, health insurance, and payments to health plans. In: Pauly, M.V., McGuire, T.G., Barros, P.P. (eds.) Handbook of health economics, vol. 2, p. 2012. Elsevier North Holland, Amsterdam (2012)Google Scholar
 4.Cao, Z., McGuire, T.G.: Servicelevel selection by HMOs in Medicare. J. Health Econ. 22(6), 915–931 (2003)CrossRefPubMedGoogle Scholar
 5.Carey C.: Government payments and insurer benefit design in Medicare. Part D: Working Paper (2014)Google Scholar
 6.Eggleston, K., Bir, A.: Measuring selection incentives in managed care: evidence from the Massachusetts state employees insurance program. J. Risk Insur. 76, 159–175 (2009)CrossRefGoogle Scholar
 7.Ellis, R.P., Jiang, S., Kuo, T.C.: Does servicelevel spending show evidence of selection across health plan types? Appl. Econ. 45(13), 1701–1712 (2013)CrossRefGoogle Scholar
 8.Eijkenaar F, Van Kleef RC, Van Veen SHCM, Van Vliet RCJA.: Research for the Dutch risk equalization model of 2015: Estimation of risk equalization weights. Research report (in Dutch), Erasmus University Rotterdam (2014)Google Scholar
 9.Ellis, R.P., McGuire, T.G.: Predictability and predictiveness in health care spending. J. Health Econ. 26(1), 25–48 (2007)CrossRefPubMedGoogle Scholar
 10.Enthoven, A.C.: The history and principles of managed competition. Health Aff. 12, 24–48 (1993)CrossRefGoogle Scholar
 11.Geruso M, Layton T. Upcoding or selection? Evidence from Medicare on squishy risk adjustment. National Bureau of Economic Research Working Paper, number W21222 (2015)Google Scholar
 12.Glazer, J., McGuire, T.G.: Optimal risk adjustment in markets with adverse selection: an application to managed care. Am. Econ. Rev. 90, 1055–1071 (2000)CrossRefGoogle Scholar
 13.Glazer, J., McGuire, T.G.: Setting health plan premiums to ensure efficient quality in health care: minimum variance optimal risk adjustment. J. Public Econ. 84, 153–173 (2002)CrossRefGoogle Scholar
 14.Kautter, J., Pope, G.C., Ingber, M., Freeman, S., Patterson, L., Cohen, M., Keenan, P.: The HHSHCC risk adjustment model for individual and small group markets under the Affordable Care Act. Medicare Medicaid Res. Rev. 4(3), E1–E11 (2014)Google Scholar
 15.Lamers, L.M., Van Vliet, R.C.J.A.: The pharmacybased cost group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy 68, 113–121 (2004)CrossRefPubMedGoogle Scholar
 16.Layton, T.J., Ellis, R.P., McGuire, T.G.: Assessing incentives for adverse selection in health plan payment systems, National Bureau of Economic Research Working Paper, number 21531 (2015)Google Scholar
 17.Lorenz, N.: Using quantile regression for optimal risk adjustment, University of Trier, Research Papers in Economics No 11/14. (2014)Google Scholar
 18.McGuire, T.G., Glazer, J., Newhouse, J.P., Normand, S.L., Shi, J., Sinaiko, A.D., Zuvekas, S.: Integrating risk adjustment and enrollee premiums in health plan payment. J. Health Econ. 32, 1263–1277 (2013)CrossRefPubMedGoogle Scholar
 19.McGuire, T.G., Newhouse, J.P., Normand, S.L., Shi, J., Zuvekas, S.H.: Assessing incentives for servicelevel selection in private health insurance exchanges. J. Health Econ. 35, 47–63 (2014)CrossRefPubMedGoogle Scholar
 20.Newhouse, J.P.: Reimbursing health plans and health providers: efficiency in production versus selection. J. Econ. Lit. 34, 1236–1263 (1996)Google Scholar
 21.Pope, G.C., Ellis, R.P., Ash, A.S., et al.: Principal inpatient diagnostic cost group model for Medicare risk adjustment. Health Care Financ. Rev. 21(3), 93–118 (2000)PubMedPubMedCentralGoogle Scholar
 22.Pope, G.C., Kautter, J., Ingber, J.J., Freeman, S., Sekar, R., Newhart, C.: Evaluation of the CMSHCC risk adjustment model. In final report, RTI project number 0209853.006, RTI International (2011)Google Scholar
 23.Prinsze, F.J., Van Vliet, R.C.J.A.: Healthbased risk adjustment: improving the pharmacybased cost group model by adding diagnostic cost groups. Inquiry 44, 469–480 (2007)PubMedGoogle Scholar
 24.Rothschild, M., Stiglitz, J.: Equilibrium in competitive insurance markets: an essay on the economics of imperfect information. Q. J. Econ. 90, 629–649 (1976)CrossRefGoogle Scholar
 25.Schokkaert, E., Van de Voorde, C.: Risk selection and the specification of the conventional risk adjustment formula. J. Health Econ. 23, 1237–1259 (2004)CrossRefPubMedGoogle Scholar
 26.Van Barneveld, E.M., Lamers, L.M., Van Vliet, R.C.J.A., Van de Ven, W.P.M.M.: Ignoring small predictable profits and losses: a new approach for measuring incentives for cream skimming. Health Care Manag. Sci. 3, 131–140 (2000)CrossRefPubMedGoogle Scholar
 27.Van de Ven, W.P.M.M., Beck, K., Buchner, F., Schokkaert, E., Schut, F.T., Shmueli, A., Wasem, J.: Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland. Health Policy 109, 226–245 (2013)CrossRefPubMedGoogle Scholar
 28.Van de Ven, W.P.M.M., Ellis, R.P.: Risk adjustment in competitive health insurance markets. In: Culyer, A.J., Newhouse, J.P. (eds.) Handbook of health economics, pp. 755–845. NorthHolland, Amsterdam (2000)Google Scholar
 29.Van de Ven, W.P.M.M., Van Kleef, R.C., Van Vliet, R.C.J.A.: Risk selection threatens quality of care for certain patients: lessons from Europe’s health insurance exchanges. Health Affairs 34, 1713–1720 (2015)CrossRefPubMedGoogle Scholar
 30.Van Kleef, R.C., Van Vliet, R.C.J.A., Van de Ven, W.P.M.M.: Risk equalization in the Netherlands: an empirical evaluation. Exp. Rev. Pharmacoecon. Outcomes Res. 13, 829–839 (2013)CrossRefGoogle Scholar
 31.Van Kleef, R.C., Van Vliet, R.C.J.A.: Prior use of durable medical equipment as a risk adjuster for healthbased capitation. Inquiry 47, 343–358 (2010)PubMedGoogle Scholar
 32.Van Kleef, R.C., Van Vliet, R.C.J.A.: Improving risk equalization using multipleyear high cost as a health indicator. Med. Care 50, 140–144 (2012)CrossRefPubMedGoogle Scholar
 33.Van Kleef, R.C., Van Vliet, R.C.J.A., Van Rooijen, E.M.: Diagnosesbased cost groups in the Dutch riskequalization model: the effects of including outpatient diagnoses. Health Policy 115, 52–59 (2014)CrossRefPubMedGoogle Scholar
 34.Van Kleef, R.C., Van Vliet, R.C.J.A., Van de Ven, W.P.M.M.: Overpaying morbidity adjusters in risk equalization models. Eur. J. Health Econ. (2015). doi: 10.1007/s1019801507292 PubMedCentralGoogle Scholar
 35.Van Veen, S.H.C.M., Van Kleef, R.C., Van de Ven, W.P.M.M., Van Vliet, R.C.J.A.: Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years. Eur. J. Health Econ. 16, 201–218 (2015)CrossRefPubMedGoogle Scholar
 36.Van Veen, S.H.C.M., Van Kleef, R.C., Van de Ven, W.P.M.M., Van Vliet, R.C.J.A.: Is there one measureoffit that fits all? A taxonomy and review of measuresoffit for riskequalization models. Med. Care Res. Rev. 72, 220–243 (2015)CrossRefPubMedGoogle Scholar
 37.Van Vliet, R.C.J.A., Van Kleef, R.C.: Followup research regarding the Dutch risk equalization of 2015: predictive value of the prior use of district nursing for future healthcare expenses. Research report (in Dutch). Erasmus University Rotterdam (2015)Google Scholar
Copyright information
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.